← Earnings Calls
DD FY2026 Q1 Raised

DuPont de Nemours, Inc. earnings call

May 05, 2026 · 08:00 ET Anne Gian-ChristofaroAntonella FranzenLori Koch earningscall_biz
Buzzberg read

Full-year adjusted EPS guidance raised to $2.35-$2.40

DuPont reported a strong Q1, beating guidance with organic growth of 2%, significant margin expansion, and double-digit EPS growth. Management raised full-year guidance, citing pricing actions to offset Middle East conflict-related cost inflation and strong operational execution. The quarter saw some disruption in the Water business from Middle East logistics, but the impact was temporary as shipments were made in April. Q1 2026 organic sales grew 2%, with operating EBITDA margin up 130 bps pro forma to 24.6%.

Buzzberg read Full-year adjusted EPS guidance raised to $2.35-$2.40 DuPont reported a strong Q1, beating guidance with organic growth of 2%, significant margin expansion, and double-digit EPS growth. Management raised full-year guidance, citing pricing actions to offset Middle East conflict-related cost inflation and strong operational execution. The quarter saw some disruption in the Water business from Middle East logistics, but the impact was temporary as shipments were made in April. Q1 2026 organic sales grew 2%, with operating EBITDA margin up 130 bps pro forma to 24.6%. Read full analysisCollapse analysis

DuPont reported a strong Q1, beating guidance with organic growth of 2%, significant margin expansion, and double-digit EPS growth. Management raised full-year guidance, citing pricing actions to offset Middle East conflict-related cost inflation and strong operational execution. The quarter saw some disruption in the Water business from Middle East logistics, but the impact was temporary as shipments were made in April. Q1 2026 organic sales grew 2%, with operating EBITDA margin up 130 bps pro forma to 24.6%.

  • Management raised FY2026 guidance for revenue and EPS, incorporating pricing to offset ~$90M of incremental input costs from the Middle East conflict.
  • Healthcare sales were up high-single-digit in Q1 and are expected to grow mid-to-high single digits for the full year.
  • The Water business was down in Q1 due to Middle East logistics disruptions, but management expects a strong rebound in the second half.
Revenue$1.681B-1% QoQ
EPS$1.65Reported
Gross margin35.81%Reported
Operating margin11.06%Reported
6 grounded callouts

What matters now

The highest-signal changes from the call.

01
Guidance

Full-year adjusted EPS guidance raised to $2.35-$2.40

02
Pricing

Pricing actions to fully offset Middle East conflict costs

03
Demand

Water business growth expected to accelerate in second half

Show 3 more callouts
04
Demand

Healthcare segment sees high single-digit organic growth in Q1

05
Buybacks

New ASR of $275 million announced under existing program

06
Portfolio

Aramids divestiture completed on April 1st

Reported period

Actuals

MetricReportedChange
Revenue$1.681B-1% QoQ
EPS$1.65Reported
Gross margin35.81%Reported
Operating margin11.06%Reported
Free cash flow$0.13B-41% QoQ
Capex$0.102BReported
Forward-looking

Forward guidance

MetricPeriodRangeMidpointStatus
EPSFY2026$2.35–$2.40$2.38Raised
Operating marginFY2026 Q2$0.43B$0.43BGuided
RevenueFY2026$7.16B–$7.21B$7.185BRaised
RevenueFY2026 Q2$1.8B$1.8BGuided
AI, capex & demand read

Management read

Tone

Confident

Management expressed confidence in their execution, raised full-year guidance, and highlighted strong order trends and productivity gains.

AI

Management AI read

Management highlighted their collaboration with Uncountable, an AI-driven platform for product and application development, to accelerate development and improve cycle time. They also mentioned expanding the use of data-enabled tools for maintenance, defect detection, and asset performance optimization.

Capex

Investment and capacity

No specific capital expenditure guidance was discussed, but the company continues to invest in digital and AI capabilities to drive operational excellence.

External signals

Supply-chain alpha · 3returns since call

A1

DuPont estimates it will take ~$90 million in incremental costs due to the Middle East conflict, and has implemented price increases and surcharges to fully offset this headwind, implying pricing power in its niche markets.

Evidence
“So overall, our expectation is around incremental costs of around 90 million, which we expect to fully cover from a top line perspective related to price and surcharges.”
A2

April sales were in line with expectations, and order trends remained strong even after price increases were implemented, suggesting minimal demand destruction from the new pricing.

Evidence
“our order trends in April were actually, you know, we have very similar demand as we have been seeing and nice increases overall on a year-over-year basis.”
A3

DuPont has shifted its full-year growth assumptions, now expecting Water to be flat in the first half and up high-single-digits in the second half due to large project timing being skewed to the second half of the year.

Evidence
“So we'll be about flat overall in water in the first half. And then we think up kind of high single digits in the second half.”
Methodology & coverage

Management-only analysis. All 0 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.